Prognostic implications of MXRA8 expression in colorectal cancer and its role in tumor progression

Abstract

Matrix Remodeling Associated 8 (MXRA8) is a type I transmembrane protein capable of modulating integrin signaling and regulating cell-cell interactions, and also functions as a receptor for multiple arthritogenic alphaviruses. Although limited numbers of studies have provided evidence indicating a potential role of MXRA8 in different types of cancer, the potential contrubition of MXRA8 in colorectal cancer (CRC) has not yet been fully elucidated. Therefore, our aim was to conduct a comprehensive analysis elucidating the prognostic value of MXRA8 in CRC. The results revealed that MXRA8 was highly expressed in CRC compared to normal tissue. Notably, there was a substantial correlation with the TNM stage, and elevated MXRA8 expression was indicative of a poorer prognosis in CRC cases. Furthermore, co-expression analysis indicated that MXRA8 is predominantly involved in hypoxia and epithelial-mesenchymal transition pathway. In conclusion, this study demonstrates the potential roles of MXRA8 in predicting CRC prognosis and contributes to the elucidation of how MXRA8 might be involved in the mechanisms underlying CRC carcinogenesis.

Keywords

• Colorectal Cancer
• MXRA8
• Prognosis
• Biomarker
• Epithelial-mesenchymal transition

References

1. References 1. L.H. Biller, D. Schrag, Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review, JAMA, 325 (2021) 669-685.
2. 2. H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 71 (2021) 209-249.
3. 3. K. Forrester, C. Almoguera, K. Han, W.E. Grizzle, M. Perucho, Detection of high incidence of K-ras oncogenes during human colon tumorigenesis, Nature, 327 (1987) 298-303.
4. 4. E.A. Kheirelseid, N. Miller, K.H. Chang, M. Nugent, M.J. Kerin, Clinical applications of gene expression in colorectal cancer, J Gastrointest Oncol, 4 (2013) 144-157.
5. 5. Z. Fang, S. Xu, Y. Xie, W. Yan, Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis, World J Surg Oncol, 19 (2021) 13.
6. 6. J. Liu, C. Dong, G. Jiang, X. Lu, Y. Liu, H. Wu, Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice, BMC Med Genomics, 13 (2020) 135.
7. 7. R. Zhang, A.S. Kim, J.M. Fox, S. Nair, K. Basore, W.B. Klimstra, R. Rimkunas, R.H. Fong, H. Lin, S. Poddar, J.E. Crowe, Jr., B.J. Doranz, D.H. Fremont, M.S. Diamond, Mxra8 is a receptor for multiple arthritogenic alphaviruses, Nature, 557 (2018) 570-574.
8. 8. Z. Xu, X. Chen, L. Song, F. Yuan, Y. Yan, Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis, Front Immunol, 13 (2022) 834595.

9. 9. L. Wu, Y. Zhou, Y. Guan, R. Xiao, J. Cai, W. Chen, M. Zheng, K. Sun, C. Chen, G. Huang, X. Zhang, Z. Qian, S. Shen, Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration, Front Oncol, 11 (2021) 756246.
10. 10. R. Kalluri, The biology and function of fibroblasts in cancer, Nat Rev Cancer, 16 (2016) 582-598.
11. 11. R. Ichihara, Y. Shiraki, Y. Mizutani, T. Iida, Y. Miyai, N. Esaki, A. Kato, S. Mii, R. Ando, M. Hayashi, H. Takami, T. Fujii, M. Takahashi, A. Enomoto, Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer, Pathol Int, 72 (2022) 161-175.
12. 12. P.G. Bhosale, S. Cristea, S. Ambatipudi, R.S. Desai, R. Kumar, A. Patil, S. Kane, A.M. Borges, A.A. Schaffer, N. Beerenwinkel, M.B. Mahimkar, Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer, Transl Oncol, 10 (2017) 396-409.
13. 13. D. Zhang, C. Qian, H. Wei, X. Qian, Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma, Front Mol Biosci, 7 (2020) 599475.
14. 14. Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res, 45 (2017) 98-102.
15. 15. T. Li, J. Fu, Z. Zeng, D. Cohen, J. Li, Q. Chen, B. Li, X.S. Liu, TIMER2.0 for analysis of tumor-infiltrating immune cells, Nucleic Acids Res, 48 (2020) 509-514.
16. 16. A.D. Redfern, L.J. Spalding, E.W. Thompson, The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome, Clin Exp Metastasis, 35 (2018) 285-308.
17. 17. G. Wang, D. Xu, Z. Zhang, X. Li, J. Shi, J. Sun, H.Z. Liu, X. Li, M. Zhou, T. Zheng, The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response, NPJ Precis Oncol, 5 (2021) 56.
18. 18. H. Li, C. Peng, C. Zhu, S. Nie, X. Qian, Z. Shi, M. Shi, Y. Liang, X. Ding, S. Zhang, B. Zhang, X. Li, G. Xu, Y. Lv, L. Wang, H. Friess, B. Kong, X. Zou, S. Shen, Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner, Clin Epigenetics, 13 (2021) 18.
19. 19. E.J. Kuipers, W.M. Grady, D. Lieberman, T. Seufferlein, J.J. Sung, P.G. Boelens, C.J. van de Velde, T. Watanabe, Colorectal cancer, Nat Rev Dis Primers, 1 (2015) 15065.
20. 20. X. Leng, J. Yang, T. Liu, C. Zhao, Z. Cao, C. Li, J. Sun, S. Zheng, A bioinformatics framework to identify the biomarkers and potential drugs for the treatment of colorectal cancer, Front Genet, 13 (2022) 1017539.
21. 21. A. Kumar, E. Rathi, S.G. Kini, Exploration of small-molecule entry disruptors for chikungunya virus by targeting matrix remodelling associated protein, Res Pharm Sci, 15 (2020) 300-311.
22. 22. L. Tan, D. Fu, F. Liu, J. Liu, Y. Zhang, X. Li, J. Gao, K. Tao, G. Wang, L. Wang, Z. Wang, MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8(+) T cell infiltration in colorectal cancer, Front Oncol, 12 (2022) 1094612.
23. 23. S. Li, W. Xu, Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment, J Cell Biochem, 121 (2020) 3952-3960.
24. 24. K.E. Simpson, K.L. Watson, R.A. Moorehead, Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses MXRA8 Levels and Impairs Breast Cancer Growth and Metastasis In Vivo, Genes (Basel), 13 (2022).
25. 25. J. Huang, L. Zhang, D. Wan, L. Zhou, S. Zheng, S. Lin, Y. Qiao, Extracellular matrix and its therapeutic potential for cancer treatment, Signal Transduct Target Ther, 6 (2021) 153.
26. 26. J. Winkler, A. Abisoye-Ogunniyan, K.J. Metcalf, Z. Werb, Concepts of extracellular matrix remodelling in tumour progression and metastasis, Nat Commun, 11 (2020) 5120.
27. 27. D.M. Gilkes, G.L. Semenza, D. Wirtz, Hypoxia and the extracellular matrix: drivers of tumour metastasis, Nat Rev Cancer, 14 (2014) 430-439.
28. 28. K. Saxena, M.K. Jolly, K. Balamurugan, Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis, Transl Oncol, 13 (2020) 100845.
29. 29. R.Y. Hapke, S.M. Haake, Hypoxia-induced epithelial to mesenchymal transition in cancer, Cancer Lett, 487 (2020) 10-20.